SWOG clinical trial number
CTSU/EA8134
InPACT- International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)
Open
Phase
Abbreviated Title
Phase 3 Intl Penile Adv Can
Status Notes
This study is open to accrual effective September 8, 2017.
Activated
09/08/2017
Research committees
Genitourinary Cancer
Treatment
Cisplatin
Ifosfamide
Surgery
Paclitaxel
Other Clinical Trials
SWOG Clinical Trial Number
S2210
S2210, "Targeted Neoadjuvant Treatment for Patients with Localized Prostate Cancer and Germline DNA Repair Deficiency"
Research Committee(s)
Genitourinary Cancer
Activated
08/14/2023
Accrual
2%
Open
Phase
SWOG Clinical Trial Number
S2200
S2200, A Phase II Randomized Trial of Cabozantinib with or Without Atezolizumab in Patients with Advanced Papillary Renal Cell Carcinoma: PAPMET2
Research Committee(s)
Genitourinary Cancer
Activated
09/19/2022
Accrual
8%
Open
Phase
SWOG Clinical Trial Number
CTSU/EA8185
Phase II Study of Bladder-SparIng ChemoradiatioN with MEDI4736 (Durvalumab) in Clinical Stage III, Node PosItive BladdeR CancEr (INSPIRE)
Research Committee(s)
Genitourinary Cancer
Activated
05/01/2021
Open
Phase